新2手机网址（www.99cx.vip）实时更新发布最新最快的新2手机网址、新2手机网址线路、新2手机网址登录网址、新2手机网址管理端、新2手机网址手机版登录网址、新2手机皇冠登录网址。

PETALING JAYA: Malaysian Genomics Resource Centre Bhd (MGRC) has entered into a strategic partnership with Saudi Arabia-based United Doctors Hospital (UDH) for collaboration in genomics and cell therapies.

In a filing with Bursa Malaysia, the genomics and biopharmaceutical specialist said the partnership is valid for three years.

Under the partnership, MGRC and UDH will take the necessary steps to encourage and promote cooperation in the sales and marketing of genetic screening tests and cell therapy products; collaboration in research and development (R&D), and other areas of cooperation in genomics and cell therapies to be mutually decided by both parties.

新2开户（www.hg108.vip）是一个开放皇冠正网即时比分、新2开户的平台。新2线上开户平台（www.hg108.vip）提供最新皇冠登录，皇冠APP下载包含新皇冠体育代理、会员APP。

UDH, located in Jeddah, Saudi Arabia, is accredited by the Saudi Central Board for Accreditation of Healthcare Institutions.

“This strategic partnership with UDH enables us to expand the geographical reach of our products and services beyond Malaysia to the Middle East and North Africa region.

“It will also enable us to collaborate on R&D with various domain specialists to enhance our suite of genetic screening tests and cell therapies,” executive director Azri Azerai said in a statement.